Gts Securities LLC Ab Cellera Biologics Inc. Call Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$2.73 - $4.73 $273 - $473
100 Added 0.72%
14,000 $41,000
Q1 2024

May 15, 2024
SELL
$4.29 - $5.97 $42,042 - $58,506
-9,800 Reduced 41.35%
13,900 $62,000
Q4 2023

Feb 14, 2024
SELL
$3.91 - $5.93 $25,415 - $38,545
-6,500 Reduced 21.52%
23,700 $135,000
Q3 2023

Nov 15, 2023
BUY
$4.6 - $7.95 $138,920 - $240,090
30,200 New
30,200 $138,000

Others Institutions Holding ABCL

# of Institutions
165
Shares Held
119M
Call Options Held
239K
Put Options Held
200K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $744M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email